COMIRNATY will be produced in BioNTech’s and Pfizer’s manufacturing sites in Europe ... Apr 20
Germany restricts the vaccine for those over 60 while Canada restriction at 55 years and older... Mar 31
Tessa announced, EMA has granted PRiority MEdicines designation to the company's lead autologous CD30 CAR-T therapy for the treatment of relapsed or refractory ... Jan 19
XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people ... Jan 15
The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard... Dec 28
EU mass vaccination programme to roll out soon... Dec 22
Fortress Biotech declares US FDA has granted breakthrough therapy designation for CUTX-101, Copper Histidinate, for the treatment of Menkes Disease ... Dec 16
Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
CHMP issues positive opinion for use of Plavix with aspirin in adults within 24 hours of minor ischemic stroke or high-risk transient ischemic attack ... Dec 12
The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European ... Dec 04
BNT162b2 is currently in Phase 3 clinical trials in the United States, Germany, Argentina, Brazil, South Africa, Turkey and other countries... Nov 20
... Nov 02
These submissions are an important step forward in the commitment to providing an additional treatment option ... Oct 20
... Oct 09
NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia... Jun 17
-Advertisements-
Wednesday, May 15, 2024
.jpeg)
